ClinConnect ClinConnect Logo
Search / Trial NCT05928598

Goals for Epilepsy Clinic Visits Trial

Launched by UNIVERSITY OF MICHIGAN · Jun 30, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Survey Quality Of Life Communication Tool Patient Provider Communication

ClinConnect Summary

The "Goals for Epilepsy Clinic Visits Trial" is a study designed to see if a new tool called the "Epilepsy Visit Planner" can help improve communication between patients with drug-resistant epilepsy and their healthcare providers. This tool is a tablet-based program that patients can use while waiting for their appointments. Researchers believe that using this planner may not only make communication better but also enhance the overall quality of life for patients. They will also evaluate how easy and acceptable the tool is for both patients and providers, which could lead to larger studies in the future.

To participate in this trial, you need to be an adult (18 years or older) with drug-resistant epilepsy and receiving care at the University of Michigan's epilepsy clinics. Unfortunately, if you don't speak English, don’t have a clear diagnosis of drug-resistant epilepsy, or have significant cognitive difficulties that would make it hard for you to complete study questionnaires, you won't be able to participate. If you join the study, you can expect to use the Epilepsy Visit Planner during your clinic visits and provide feedback about your experience. This study is currently recruiting participants and is open to anyone within the specified age range.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria - Patient Participants:
  • Adults with drug-resistant epilepsy
  • Participants receiving care through the Epilepsy clinics at the University of Michigan
  • Exclusion Criteria - Patient Participants:
  • \<18 years old
  • Non-English speaking
  • Do not clearly have drug-resistant epilepsy
  • Moderate-to-severe cognitive impairment that precludes study questionnaire completion
  • Inclusion Criteria - Provider Participants:
  • -University of Michigan epilepsy providers
  • Exclusion Criteria - Provider Participants:
  • -Not University of Michigan epilepsy providers

About University Of Michigan

The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.

Locations

Ann Arbor, Michigan, United States

Patients applied

0 patients applied

Trial Officials

Chloe Hill, MD

Principal Investigator

University of Michigan

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported